When Provider CSAO was founded in 2022, the question of whether pharmacists would ever be formally recognized by Medicare — and fairly compensated — as healthcare providers hung unanswered in Congress. We built this company on the conviction that the answer would be yes, and that the pharmacists didn’t have to wait. We knew that the pharmacist who was prepared when it happened would have a decisive advantage over those who waited. That moment has arrived. On May 21, 2026, the

For April 2026, two states stood out: Kentucky and Colorado.

The Evolution of the First Pharmacy CSAO The Clinical Services Administrative Organization (CSAO), represents a paradigm shift in how pharmacies operate, bill, and thrive in modern healthcare. As an organization our goal is to facilitate a simple and sustainable infrastructure for pharmacist provided clinical services reimbursement. For too long the traditional PSAO model has been the primary source of revenue supporting the pharmaceutical industry. This model centers the rei

The AMAs stance on pharmacist expansion of scope of practice is plain and transparent. “The fight against scope creep” treats healthcare as if it were a turf war rather than a complex problem requiring the attention and expertise of an interdisciplinary team. While the AMA leans on obstructionist rhetoric, organizations like Provider CSAO will continue to work towards the goal of expanding patient access to reimbursable primary care services. The American healthcare system

In the dynamic landscape of healthcare, pharmacies play a crucial role in patient care, and maximizing revenue is essential for their sustained growth. One new but overlooked avenue for increasing revenue is the utilization of Evaluation and Management (E&M) codes. These codes, traditionally associated with physician services which you (yes, even as a Pharmacist) can now bill to commercial payers for and will prove to be a successful clinical service for boosting pharmacy rev

Pharmacies play a crucial role in the healthcare system by ensuring that patients have access to necessary medications and access to expanded care. However, over the years pharmacies have dealt with major financial challenges due to a complex reimbursement system–particularly the Dirty, Insufferable, Ridiculous, ahem, Direct and Indirect Remuneration (DIR) fees. Fortunately it seems that the government is beginning to address these, and in 2024 the landscape of DIR fees for p

FENO measurement testing, also known as Fractional Exhaled Nitric Oxide testing, is a non-invasive procedure used to measure the levels of nitric oxide in a person's breath. This test is often used to diagnose and monitor patients with asthma, as elevated nitric oxide levels in the breath can be a sign of airway inflammation. Asthma is another common disease that clinical pharmacists can help alleviate. Offering this testing in pharmacies has several benefits including improv

As a pharmacy owner, what are the most important aspects of ensuring your pharmacy is successful? It may be presumptuous, but our guess would include increasing revenue and helping your community to stay healthy. Independent pharmacies are special precisely because they have a focus on community. Miss Judy comes in a couple times per month, and lives just down the street–and you know her. What’s more, you care about her health. She’s one of the 93% of Americans with diabetes